On the contrary @jwoody1000
I am indicating how extremely valuable our IP is worth
For multiple drugs that are out of patent, there are countless generic versions
Anything that Starpharma develops and puts into the market (I am talking in this instance out of patent drugs), the generics of these will be obsolete
Examples of this are DEP® docetaxel, Cabazitaxel, and Irinotecan
On the contrary @jwoody1000 I am indicating how extremely...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.5¢ | $13.46K | 116.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 374820 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 13759 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 12.0¢ | 11.5¢ | 399474 | ||
| Last updated 14.56pm 16/05/2024 ? | |||||
| SPL (ASX) Chart |